Literature DB >> 35321882

SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients.

Bo Zhai1, Karen Clarke2, David L Bauer3, Krissy K Moehling Geffel2, Saran Kupul1, Lucas J Schratz1, M Patricia Nowalk2, Anita K McElroy1,4, James B McLachlan3, Richard K Zimmerman2,4, John F Alcorn5,4.   

Abstract

COVID-19 has had an unprecedented global impact on human health. Understanding the Ab memory responses to infection is one tool needed to effectively control the pandemic. Among 173 outpatients who had virologically confirmed SARS-CoV-2 infection, we evaluated serum Ab concentrations, microneutralization activity, and enumerated SARS-CoV-2-specific B cells in convalescent human blood specimens. Serum Ab concentrations were variable, allowing for stratification of the cohort into high and low responders. Neither participant sex, the timing of blood sampling following the onset of illness, nor the number of SARS-CoV-2 spike protein-specific B cells correlated with serum Ab concentration. Serum Ab concentration was positively associated with microneutralization activity and participant age, with participants under the age of 30 showing the lowest Ab level. These data suggest that young adult outpatients did not generate as robust Ab memory, compared with older adults. Body mass index was also positively correlated with serum Ab levels. Multivariate analyses showed that participant age and body mass index were independently associated with Ab levels. These findings have direct implications for public health policy and current vaccine efforts. Knowledge gained regarding Ab memory following infection will inform the need for vaccination in those previously infected and allow for a better approximation of population-wide protective immunity.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35321882      PMCID: PMC8976825          DOI: 10.4049/jimmunol.2101156

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Antibody responses to SARS-CoV-2 in patients with COVID-19.

Authors:  Quan-Xin Long; Bai-Zhong Liu; Hai-Jun Deng; Gui-Cheng Wu; Kun Deng; Yao-Kai Chen; Pu Liao; Jing-Fu Qiu; Yong Lin; Xue-Fei Cai; De-Qiang Wang; Yuan Hu; Ji-Hua Ren; Ni Tang; Yin-Yin Xu; Li-Hua Yu; Zhan Mo; Fang Gong; Xiao-Li Zhang; Wen-Guang Tian; Li Hu; Xian-Xiang Zhang; Jiang-Lin Xiang; Hong-Xin Du; Hua-Wen Liu; Chun-Hui Lang; Xiao-He Luo; Shao-Bo Wu; Xiao-Ping Cui; Zheng Zhou; Man-Man Zhu; Jing Wang; Cheng-Jun Xue; Xiao-Feng Li; Li Wang; Zhi-Jie Li; Kun Wang; Chang-Chun Niu; Qing-Jun Yang; Xiao-Jun Tang; Yong Zhang; Xia-Mao Liu; Jin-Jing Li; De-Chun Zhang; Fan Zhang; Ping Liu; Jun Yuan; Qin Li; Jie-Li Hu; Juan Chen; Ai-Long Huang
Journal:  Nat Med       Date:  2020-04-29       Impact factor: 53.440

2.  The association between obesity and peak antibody titer response in COVID-19 infection.

Authors:  Shelly Soffer; Benjamin S Glicksberg; Eyal Zimlichman; Orly Efros; Matthew A Levin; Robert Freeman; David L Reich; Eyal Klang
Journal:  Obesity (Silver Spring)       Date:  2021-08-02       Impact factor: 9.298

3.  A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients.

Authors:  Allison N Grossberg; Lilia A Koza; Aurélie Ledreux; Chad Prusmack; Hari Krishnan Krishnamurthy; Vasanth Jayaraman; Ann-Charlotte Granholm; Daniel A Linseman
Journal:  Nat Commun       Date:  2021-02-02       Impact factor: 14.919

4.  Postconvalescent SARS-CoV-2 IgG and Neutralizing Antibodies are Elevated in Individuals with Poor Metabolic Health.

Authors:  Sabrina E Racine-Brzostek; He S Yang; Gwendolyne A Jack; Zhengming Chen; Amy Chadburn; Thomas J Ketas; Erik Francomano; P J Klasse; John P Moore; Kathleen A McDonough; Roxanne C Girardin; Alan P Dupuis; Anne F Payne; Lucy X Ma; Jacob Sweeney; Elaine Zhong; Jim Yee; Melissa M Cushing; Zhen Zhao
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

Review 5.  Antibody Responses in COVID-19: A Review.

Authors:  Mateo Chvatal-Medina; Yorjagis Mendez-Cortina; Pablo J Patiño; Paula A Velilla; Maria T Rugeles
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

6.  Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination.

Authors:  Li Tang; Sean Cherry; Elaine I Tuomanen; Ericka Kirkpatrick Roubidoux; Chun Yang Lin; Kim J Allison; Ashleigh Gowen; Pamela Freiden; E Kaitlynn Allen; Yin Su; Aditya H Gaur; Jeremie H Estepp; Maureen A McGargill; Florian Krammer; Paul G Thomas; Stacey Schultz-Cherry; Joshua Wolf
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

7.  Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication.

Authors:  Tuba Ozgocer; Şeyda N Dagli; Mehmet R Ceylan; Faruk Disli; Cihat Ucar; Sedat Yildiz
Journal:  J Med Virol       Date:  2021-11-18       Impact factor: 20.693

8.  Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.

Authors:  Sabra L Klein; Andrew Pekosz; Han-Sol Park; Rebecca L Ursin; Janna R Shapiro; Sarah E Benner; Kirsten Littlefield; Swetha Kumar; Harnish Mukesh Naik; Michael J Betenbaugh; Ruchee Shrestha; Annie A Wu; Robert M Hughes; Imani Burgess; Patricio Caturegli; Oliver Laeyendecker; Thomas C Quinn; David Sullivan; Shmuel Shoham; Andrew D Redd; Evan M Bloch; Arturo Casadevall; Aaron Ar Tobian
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

9.  Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen.

Authors:  Justin J Taylor; Ryan J Martinez; Philip J Titcombe; Laura O Barsness; Stephanie R Thomas; Na Zhang; Shoshana D Katzman; Marc K Jenkins; Daniel L Mueller
Journal:  J Exp Med       Date:  2012-10-15       Impact factor: 14.307

10.  Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.

Authors:  Jennifer M Sasson; Joseph J Campo; Rebecca M Carpenter; Mary K Young; Arlo Z Randall; Krista Trappl-Kimmons; Amit Oberai; Christopher Hung; Joshua Edgar; Andy A Teng; Jozelyn V Pablo; Xiaowu Liang; Angela Yee; William A Petri; David Camerini
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.